Johnson & Johnson's Receives Criticism From FDA on QC Procedures

Federal drug regulators are criticizing Johnson & Johnson’s consumer product division’s quality control procedures again after inspectors uncovered a number of violations, including the company’s failure to adequately review more than 60 medical-related complaints about a vaginal moisturizer product.
May 31, 2012
Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates